ORKA · Oruka Therapeutics, Inc.
Market Cap
$6.21B
Shares
66.21M
Oruka Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Oruka Therapeutics, Inc. (ORKA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-06-03
Oruka Therapeutics, Inc. (ORKA) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
Oruka Therapeutics, Inc. (ORKA) Q1 2026 Earnings Call Transcript
Confident tone
ORCA001 efficacy in plaque psoriasis
Study design / Everlast A and B
Annual dosing potential / PK profile
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–2 of 2 earnings calls
Key facts
CIK
907654
CUSIP
687604108
13F (30d)
228 filings
223 filers
Visit website
Investor relations